Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.03−0.66 (-1.51%)
Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –
Boston Scientific operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Boston Scientific's operating income for the twelve months ending Jun 30, 2026 was $4.15B, up 31.9% year over year. For fiscal 2025 it was $3.61B, up 38.8% from the year before. The highest annual figure on record is $3.61B in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.61B | +38.8% |
| FY2024 | Dec 31, 2024 | $2.60B | +11.1% |
| FY2023 | Dec 31, 2023 | $2.34B | +42.1% |
| FY2022 | Dec 31, 2022 | $1.65B | +37.5% |
| FY2021 | Dec 31, 2021 | $1.20B | – |
| FY2020 | Dec 31, 2020 | -$80.00M | -105.3% |
| FY2019 | Dec 31, 2019 | $1.52B | +0.8% |
| FY2018 | Dec 31, 2018 | $1.51B | +17.2% |
| FY2017 | Dec 31, 2017 | $1.29B | +187.5% |
| FY2016 | Dec 31, 2016 | $447.00M | – |
| FY2015 | Dec 31, 2015 | -$283.00M | – |
| FY2014 | Dec 31, 2014 | -$301.00M | -350.8% |
| FY2013 | Dec 31, 2013 | $120.00M | – |
| FY2012 | Dec 31, 2012 | -$3.87B | -527.9% |
| FY2011 | Dec 31, 2011 | $904.00M | – |
| FY2010 | Dec 31, 2010 | -$656.00M | – |
| FY2009 | Dec 31, 2009 | -$894.00M | – |
| FY2008 | Dec 31, 2008 | -$1.51B | – |
| FY2007 | Dec 31, 2007 | -$14.00M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.18B | +43.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.10B | +19.5% |
| Q4 FY2025 | Dec 31, 2025 | $825.00M | +22.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.05B | +43.0% |
| Q2 FY2025 | Jun 30, 2025 | $819.00M | +57.5% |
| Q1 FY2025 | Mar 31, 2025 | $921.00M | +36.4% |
| Q4 FY2024 | Dec 31, 2024 | $675.00M | +15.6% |
| Q3 FY2024 | Sep 30, 2024 | $733.00M | +5.8% |
| Q2 FY2024 | Jun 30, 2024 | $520.00M | +1.2% |
| Q1 FY2024 | Mar 31, 2024 | $675.00M | +22.3% |
| Q4 FY2023 | Dec 31, 2023 | $584.00M | +45.3% |
| Q3 FY2023 | Sep 30, 2023 | $693.00M | +93.6% |
| Q2 FY2023 | Jun 30, 2023 | $514.00M | +21.5% |
| Q1 FY2023 | Mar 31, 2023 | $552.00M | +18.5% |
| Q4 FY2022 | Dec 31, 2022 | $402.00M | +123.3% |
| Q3 FY2022 | Sep 30, 2022 | $358.00M | -7.5% |
| Q2 FY2022 | Jun 30, 2022 | $423.00M | +61.5% |
| Q1 FY2022 | Mar 31, 2022 | $466.00M | +25.9% |
| Q4 FY2021 | Dec 31, 2021 | $180.00M | +260.0% |
| Q3 FY2021 | Sep 30, 2021 | $387.00M | – |
| Q2 FY2021 | Jun 30, 2021 | $262.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $370.00M | +153.4% |
| Q4 FY2020 | Dec 31, 2020 | $50.00M | -76.2% |
| Q3 FY2020 | Sep 30, 2020 | -$205.00M | -153.5% |
| Q2 FY2020 | Jun 30, 2020 | -$71.00M | -118.5% |
| Q1 FY2020 | Mar 31, 2020 | $146.00M | -73.0% |
| Q4 FY2019 | Dec 31, 2019 | $210.00M | -34.2% |
| Q3 FY2019 | Sep 30, 2019 | $383.00M | -1.3% |
| Q2 FY2019 | Jun 30, 2019 | $384.00M | -2.0% |
| Q1 FY2019 | Mar 31, 2019 | $541.00M | +32.9% |
| Q4 FY2018 | Dec 31, 2018 | $319.00M | +0.3% |
| Q3 FY2018 | Sep 30, 2018 | $388.00M | +2.9% |
| Q2 FY2018 | Jun 30, 2018 | $392.00M | +74.2% |
| Q1 FY2018 | Mar 31, 2018 | $407.00M | +11.8% |
| Q4 FY2017 | Dec 31, 2017 | $318.00M | +127.1% |
| Q3 FY2017 | Sep 30, 2017 | $377.00M | +8.3% |
| Q2 FY2017 | Jun 30, 2017 | $225.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $364.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $140.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $348.00M | – |
See a number that looks wrong?